Announcements Trials
Browse Landscape

Status

Recruiting 381Active not recruiting 189Not yet recruiting 94Completed 91Terminated 24Enrolling by invitation 8Suspended 7Withdrawn 3Available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Sarcoma 6Thoracic 5Other hematologic neoplasm 4Genitourinary 4Gastrointestinal 4CNS 4Breast 4Lymphoid 3Tumor-Agnostic 2Myeloid 2Gynecologic 2Dermatologic 2Head & Neck 1Endocrine 1

Conditions

Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Osteosarcoma 1Neurofibrosarcoma 1Melanoma 1Colorectal Neoplasms 1Chordoma 1Chondrosarcoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Gynecologic × 90 days × Clear all
NCT06751524 2026-05-15

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Agenus Inc.

Available
DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Aveni Foundation

Available
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡